Christopher M Smith
CIK 1436707 · Chief Executive Officer · last filed 2026-06-04
Christopher M Smith is a Chief Executive Officer who has filed 25 SEC Form 4 insider transactions across 7 companies since 2008. The most recent filing, for PACB, was dated Jun 4, 2026. Across all open-market trades the lifetime net is −$8.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $10.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$10.80M
7
25
-$8.00M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PACB | Director | 54,099 | $1.40 | $75.7K | $0 | 3 | 2026-06-04 |
| NEO | Chief Executive Officer | 655,652 | $15.46 | $10.13M | $0 | 7 | 2025-02-25 |
| QDEL | Director | 35,577 | $16.58 | $589.9K | $0 | 5 | 2023-06-08 |
| Akouos, Inc. (AKUS) Delisted | Director | — | $13.29 | — | $0 | 2 | 2022-06-27 |
| Ortho Clinical Diagnostics Holdings plc (OCDX) Delisted | Chairman and CEO | 467,360 | $17.63 | $8.24M | -$8.00M | 2 | 2022-01-05 |
| Startek, Inc. (SRT) Delisted | Director | 21,950 | $4.42 | $97.0K | $0 | 3 | 2011-10-04 |
| XTNT | Director | — | $0.41 | — | $0 | 1 | 2008-06-19 |
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-04 | PACB | Grant (A) | — | $0 | EDGAR |
| 2025-06-06 | PACB | Grant (A) | — | $0 | EDGAR |
| 2025-02-25 | NEO | Mixed | +43,346 | $0 | EDGAR |
| 2025-02-03 | PACB | Grant (A) | +54,099 | $0 | EDGAR |
| 2024-12-04 | NEO | Mixed | +29,150 | -$281.0K | EDGAR |
| 2024-08-19 | NEO | Tax (F) | −33,130 | $0 | EDGAR |
| 2024-05-14 | NEO | Mixed | +77,213 | -$281.0K | EDGAR |
| 2024-02-27 | NEO | Grant (A) | — | $0 | EDGAR |
| 2023-06-08 | QDEL | Mixed | +2,248 | $0 | EDGAR |
| 2023-05-31 | QDEL | Tax (F) | −1,225 | -$104.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.